Overview

Inflammation and Stem Cells in Diabetic and Chronic Kidney Disease

Status:
Recruiting
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The proposed studies will examine the effect of fisetin on adipose tissue-derived mesenchymal stem/stromal cell function, kidney function, markers of inflammation, and physical function in individuals with advanced chronic kidney disease.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic